A Naturalistic Study of Adolescents and Young Adults in Treatment for Opioid Dependence

Completed

Conditions studied: Opioid Dependence

In brief

Many buprenorphine treatment programs do not have services dedicated to adolescents and young adults. As a precursor to developing and evaluating an adolescent and young adult buprenorphine treatment program at APT Foundation Inc, we propose to conduct a 1 year prospective study of 16 to 25 year old treatment-seeking individuals enrolled in the APT Adolescent and Young Adult Suboxone Program

Key facts

Study ID

NCT02718352

Run by

Yale University

People needed

8

Starts

2016-03-01

Expected to finish

2018-03-01

Last updated by the study team

2018-06-27

Who can join

Age: 16 and older, up to 25. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Ages 16 through 25 at time of induction
• Meet criteria for enrollment in the APT Adolescent and Young Adult Suboxone Program (Opioid Dependence per DSM-V criteria; no contraindications to buprenorphine (concomitant benzodiazepine, alcohol use, sedative use),
• Stable enough to participate in outpatient care/intensive outpatient care for at least 12 weeks;
• Can commit to at least 12 weeks of treatment through the APT Adolescent and Young Adult Suboxone Program
• Are willing to provide locator information for follow-up.
• Are fluent in English and have a 6th grader or higher reading level

You may not qualify if…

• Have an untreated bipolar or schizophrenic disorder, or active suicidal ideation
• Are physically dependent on alcohol, benzodiazepines, or other sedatives.
• Are in custody of the Department of Children and Families

Where it is running

• APT Foundation — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.